Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 8 | 2023 | 241 | 1.390 |
Why?
|
| Clinical Decision-Making | 2 | 2021 | 61 | 0.870 |
Why?
|
| Clinical Competence | 10 | 2019 | 218 | 0.740 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 117 | 0.670 |
Why?
|
| Brain Ischemia | 6 | 2020 | 82 | 0.670 |
Why?
|
| Education, Medical | 3 | 2011 | 64 | 0.600 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2021 | 811 | 0.550 |
Why?
|
| Emergency Medical Technicians | 6 | 2006 | 10 | 0.520 |
Why?
|
| Emergency Medical Services | 6 | 2005 | 78 | 0.510 |
Why?
|
| Brain | 1 | 2021 | 712 | 0.500 |
Why?
|
| Emergency Treatment | 3 | 2005 | 26 | 0.450 |
Why?
|
| Internationality | 1 | 2011 | 31 | 0.360 |
Why?
|
| Professional Role | 1 | 2011 | 42 | 0.350 |
Why?
|
| Computer Simulation | 5 | 2005 | 221 | 0.350 |
Why?
|
| Physicians | 1 | 2011 | 81 | 0.340 |
Why?
|
| Neurology | 3 | 2005 | 10 | 0.330 |
Why?
|
| Humans | 35 | 2023 | 27167 | 0.300 |
Why?
|
| Thrombolytic Therapy | 4 | 2021 | 37 | 0.290 |
Why?
|
| Problem-Based Learning | 3 | 2019 | 60 | 0.280 |
Why?
|
| Retrospective Studies | 7 | 2022 | 2453 | 0.260 |
Why?
|
| Tissue Plasminogen Activator | 3 | 2021 | 35 | 0.240 |
Why?
|
| Bioterrorism | 1 | 2005 | 28 | 0.240 |
Why?
|
| Infection Control | 1 | 2005 | 32 | 0.230 |
Why?
|
| Intracranial Aneurysm | 2 | 2017 | 55 | 0.230 |
Why?
|
| Diagnosis, Differential | 2 | 2021 | 367 | 0.220 |
Why?
|
| Pilot Projects | 6 | 2023 | 397 | 0.210 |
Why?
|
| Nocardia Infections | 1 | 2003 | 4 | 0.210 |
Why?
|
| Opportunistic Infections | 1 | 2003 | 15 | 0.210 |
Why?
|
| Clinical Clerkship | 1 | 2003 | 20 | 0.210 |
Why?
|
| Lung Diseases | 1 | 2003 | 42 | 0.200 |
Why?
|
| Fibrinolytic Agents | 2 | 2021 | 68 | 0.200 |
Why?
|
| Antineoplastic Agents | 2 | 2021 | 660 | 0.200 |
Why?
|
| Aged, 80 and over | 8 | 2021 | 1944 | 0.200 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 472 | 0.190 |
Why?
|
| Terrorism | 3 | 2006 | 10 | 0.190 |
Why?
|
| Hydrocephalus | 1 | 2022 | 51 | 0.190 |
Why?
|
| Infusions, Intravenous | 1 | 2021 | 99 | 0.180 |
Why?
|
| Hyperglycemia | 1 | 2022 | 78 | 0.180 |
Why?
|
| Treatment Outcome | 4 | 2021 | 2286 | 0.180 |
Why?
|
| Thrombectomy | 1 | 2020 | 26 | 0.170 |
Why?
|
| Voluntary Health Agencies | 1 | 2000 | 1 | 0.170 |
Why?
|
| State Health Plans | 1 | 2000 | 3 | 0.170 |
Why?
|
| Myocardial Ischemia | 1 | 2000 | 73 | 0.170 |
Why?
|
| Patient Simulation | 3 | 2005 | 13 | 0.170 |
Why?
|
| Health Occupations | 1 | 2019 | 8 | 0.160 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2021 | 122 | 0.160 |
Why?
|
| Health Education | 1 | 2000 | 71 | 0.160 |
Why?
|
| Terminology as Topic | 1 | 2019 | 53 | 0.160 |
Why?
|
| Health Personnel | 1 | 2000 | 91 | 0.160 |
Why?
|
| Brain Infarction | 2 | 2020 | 10 | 0.160 |
Why?
|
| Aged | 9 | 2021 | 5234 | 0.160 |
Why?
|
| Concept Formation | 1 | 2018 | 7 | 0.150 |
Why?
|
| Thinking | 1 | 2018 | 11 | 0.150 |
Why?
|
| Middle Aged | 11 | 2021 | 6913 | 0.150 |
Why?
|
| Cerebral Hemorrhage | 2 | 2022 | 90 | 0.150 |
Why?
|
| Program Evaluation | 3 | 2006 | 162 | 0.150 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 235 | 0.140 |
Why?
|
| Curriculum | 6 | 2006 | 273 | 0.140 |
Why?
|
| Aneurysm, Ruptured | 1 | 2017 | 17 | 0.140 |
Why?
|
| Fucosyltransferases | 1 | 2016 | 4 | 0.130 |
Why?
|
| United States | 4 | 2005 | 2068 | 0.130 |
Why?
|
| Bronchiectasis | 1 | 2016 | 3 | 0.130 |
Why?
|
| Male | 13 | 2021 | 13040 | 0.130 |
Why?
|
| Internal Medicine | 2 | 2002 | 28 | 0.120 |
Why?
|
| Inservice Training | 2 | 2006 | 9 | 0.120 |
Why?
|
| Adult | 10 | 2020 | 7506 | 0.120 |
Why?
|
| Furans | 1 | 2014 | 5 | 0.120 |
Why?
|
| Lignans | 1 | 2014 | 10 | 0.120 |
Why?
|
| Stents | 2 | 2012 | 116 | 0.120 |
Why?
|
| Quercetin | 1 | 2014 | 14 | 0.120 |
Why?
|
| Multimedia | 2 | 2005 | 7 | 0.120 |
Why?
|
| Internship and Residency | 3 | 2005 | 228 | 0.110 |
Why?
|
| Female | 12 | 2021 | 14661 | 0.110 |
Why?
|
| Platelet Count | 1 | 2014 | 111 | 0.110 |
Why?
|
| Program Development | 2 | 2006 | 75 | 0.100 |
Why?
|
| Blood Coagulation | 1 | 2014 | 116 | 0.100 |
Why?
|
| Neoplasms | 1 | 2021 | 768 | 0.100 |
Why?
|
| Mechanical Thrombolysis | 1 | 2012 | 3 | 0.100 |
Why?
|
| Endovascular Procedures | 1 | 2012 | 61 | 0.100 |
Why?
|
| Students, Medical | 3 | 2005 | 94 | 0.100 |
Why?
|
| Blood Platelets | 1 | 2014 | 203 | 0.100 |
Why?
|
| Prospective Studies | 4 | 2021 | 1221 | 0.100 |
Why?
|
| Prostatic Neoplasms | 1 | 2014 | 271 | 0.090 |
Why?
|
| Educational Measurement | 3 | 2019 | 125 | 0.090 |
Why?
|
| Florida | 7 | 2006 | 54 | 0.090 |
Why?
|
| Cell Proliferation | 1 | 2014 | 775 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2016 | 466 | 0.090 |
Why?
|
| Coronary Artery Bypass | 1 | 2012 | 68 | 0.090 |
Why?
|
| Health Services Needs and Demand | 1 | 2011 | 37 | 0.090 |
Why?
|
| Global Health | 1 | 2011 | 43 | 0.090 |
Why?
|
| Cerebral Angiography | 3 | 2017 | 38 | 0.090 |
Why?
|
| Time Factors | 3 | 2020 | 1571 | 0.080 |
Why?
|
| Biomarkers | 2 | 2023 | 738 | 0.080 |
Why?
|
| Personnel Management | 1 | 1988 | 4 | 0.080 |
Why?
|
| Personnel Selection | 1 | 1988 | 7 | 0.080 |
Why?
|
| Disaster Planning | 1 | 2006 | 24 | 0.070 |
Why?
|
| Young Adult | 3 | 2020 | 2633 | 0.060 |
Why?
|
| Protective Clothing | 1 | 2005 | 4 | 0.060 |
Why?
|
| Toxins, Biological | 1 | 2005 | 4 | 0.060 |
Why?
|
| Decontamination | 1 | 2005 | 8 | 0.060 |
Why?
|
| Virus Diseases | 1 | 2005 | 38 | 0.060 |
Why?
|
| Cardiology | 2 | 2002 | 47 | 0.060 |
Why?
|
| Bacterial Infections | 1 | 2005 | 54 | 0.060 |
Why?
|
| Anesthesiology | 2 | 2001 | 18 | 0.060 |
Why?
|
| Education, Continuing | 2 | 2001 | 11 | 0.060 |
Why?
|
| Plasminogen Activators | 2 | 2000 | 7 | 0.060 |
Why?
|
| Alanine | 1 | 2023 | 40 | 0.050 |
Why?
|
| Blood Volume | 1 | 2022 | 8 | 0.050 |
Why?
|
| Sphingolipids | 1 | 2022 | 20 | 0.050 |
Why?
|
| Competitive Behavior | 1 | 2001 | 17 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 405 | 0.050 |
Why?
|
| Task Performance and Analysis | 1 | 2001 | 42 | 0.050 |
Why?
|
| Patient Care Team | 1 | 2001 | 63 | 0.050 |
Why?
|
| Amino Acids | 1 | 2022 | 82 | 0.050 |
Why?
|
| Metabolomics | 1 | 2022 | 82 | 0.050 |
Why?
|
| Education, Medical, Graduate | 1 | 2001 | 103 | 0.040 |
Why?
|
| Emergency Medical Service Communication Systems | 1 | 2000 | 1 | 0.040 |
Why?
|
| Prognosis | 1 | 2003 | 763 | 0.040 |
Why?
|
| Bone Marrow | 1 | 2021 | 76 | 0.040 |
Why?
|
| Skilled Nursing Facilities | 1 | 2020 | 3 | 0.040 |
Why?
|
| Hospices | 1 | 2020 | 6 | 0.040 |
Why?
|
| Feces | 1 | 2021 | 107 | 0.040 |
Why?
|
| Long-Term Care | 1 | 2020 | 32 | 0.040 |
Why?
|
| Mississippi | 1 | 2000 | 5 | 0.040 |
Why?
|
| Disability Evaluation | 1 | 2020 | 53 | 0.040 |
Why?
|
| Organizational Objectives | 1 | 2000 | 16 | 0.040 |
Why?
|
| Patient Advocacy | 1 | 2000 | 16 | 0.040 |
Why?
|
| Propensity Score | 1 | 2020 | 54 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2021 | 320 | 0.040 |
Why?
|
| DNA, Bacterial | 1 | 2021 | 302 | 0.040 |
Why?
|
| Teaching Materials | 1 | 1999 | 6 | 0.040 |
Why?
|
| Educational Technology | 1 | 1999 | 6 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2000 | 91 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2020 | 112 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2020 | 145 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2020 | 97 | 0.040 |
Why?
|
| Adolescent | 3 | 2017 | 2993 | 0.040 |
Why?
|
| Age Factors | 1 | 2020 | 725 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2020 | 598 | 0.040 |
Why?
|
| Myocardial Infarction | 1 | 2000 | 342 | 0.040 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2017 | 28 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2018 | 176 | 0.030 |
Why?
|
| Minority Groups | 1 | 2017 | 64 | 0.030 |
Why?
|
| Urban Population | 1 | 2017 | 72 | 0.030 |
Why?
|
| Sputum | 1 | 2016 | 7 | 0.030 |
Why?
|
| Poverty | 1 | 2017 | 82 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2016 | 26 | 0.030 |
Why?
|
| Pseudomonas Infections | 1 | 2016 | 24 | 0.030 |
Why?
|
| Bronchoscopy | 1 | 2016 | 34 | 0.030 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2016 | 62 | 0.030 |
Why?
|
| Biopsy | 1 | 2016 | 202 | 0.030 |
Why?
|
| Prevalence | 1 | 2017 | 478 | 0.030 |
Why?
|
| Schools, Medical | 2 | 2002 | 46 | 0.030 |
Why?
|
| Genotype | 1 | 2016 | 444 | 0.030 |
Why?
|
| Microbiota | 1 | 2016 | 81 | 0.030 |
Why?
|
| Ischemic Attack, Transient | 1 | 1995 | 25 | 0.030 |
Why?
|
| Receptors, Androgen | 1 | 2014 | 25 | 0.030 |
Why?
|
| Cerebrovascular Disorders | 1 | 1995 | 46 | 0.030 |
Why?
|
| Risk Factors | 1 | 2020 | 2038 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2014 | 100 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 446 | 0.030 |
Why?
|
| Androgens | 1 | 2014 | 47 | 0.030 |
Why?
|
| Disease Progression | 1 | 2016 | 458 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2014 | 92 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 133 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 153 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2006 | 934 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 589 | 0.030 |
Why?
|
| Functional Laterality | 1 | 2012 | 62 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2005 | 751 | 0.020 |
Why?
|
| Models, Educational | 2 | 2003 | 20 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2012 | 150 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2014 | 281 | 0.020 |
Why?
|
| Child | 1 | 2017 | 2158 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 1271 | 0.020 |
Why?
|
| Remission, Spontaneous | 1 | 1990 | 8 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 1990 | 21 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 931 | 0.020 |
Why?
|
| Chicago | 1 | 1988 | 6 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 1988 | 77 | 0.020 |
Why?
|
| Faculty, Medical | 1 | 1988 | 51 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2014 | 1379 | 0.020 |
Why?
|
| Interpersonal Relations | 1 | 1988 | 64 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 1988 | 151 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2012 | 606 | 0.020 |
Why?
|
| Certification | 1 | 2006 | 15 | 0.020 |
Why?
|
| Competency-Based Education | 1 | 2003 | 16 | 0.010 |
Why?
|
| Professional Competence | 1 | 2003 | 37 | 0.010 |
Why?
|
| Universities | 1 | 2003 | 116 | 0.010 |
Why?
|
| Planning Techniques | 1 | 2001 | 7 | 0.010 |
Why?
|
| Organizational Innovation | 1 | 2000 | 19 | 0.010 |
Why?
|
| Physician-Patient Relations | 1 | 2002 | 112 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 2000 | 45 | 0.010 |
Why?
|
| Triage | 1 | 2000 | 32 | 0.010 |
Why?
|
| Physical Examination | 1 | 2000 | 53 | 0.010 |
Why?
|
| General Surgery | 1 | 1999 | 53 | 0.010 |
Why?
|
| Laparoscopy | 1 | 1999 | 143 | 0.010 |
Why?
|
| Embolism | 1 | 1995 | 14 | 0.010 |
Why?
|
| Hematologic Diseases | 1 | 1995 | 10 | 0.010 |
Why?
|
| Arteriosclerosis | 1 | 1995 | 29 | 0.010 |
Why?
|
| Heart Diseases | 1 | 1995 | 69 | 0.010 |
Why?
|
| Vascular Diseases | 1 | 1995 | 67 | 0.010 |
Why?
|